Get started
Author

Fei Li

Gastrodin ameliorates subacute phase cerebral ischemia-reperfusion injury by inhibiting inflammation and apoptosis in rats
2016 · Bo Liu, Fei Li, et al. · Molecular Medicine Reports · 82
Bone marrow mesenchymal stem cell-derived exosomes induce the Th17/Treg imbalance in immune thrombocytopenia through miR-146a-5p/IRAK1 axis
2021 · Yue He, Dexiang Ji, et al. · Human Cell · 37
Naringin protects against steroid‑induced avascular necrosis of the femoral head through upregulation of PPARγ and activation of the Notch signaling pathway
2017 · Donghong Huang, Zhanchun Li, et al. · Molecular Medicine Reports · 16
PDF
Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study
2021 · Rui Zhang, Lili Wang, et al. · Cancer Medicine · 13
PDF
Efficacy, safety, and survival findings after long‐term follow‐up of ZGJAK002 : A phase 2 study comparing jaktinib at 100 mg twice daily ( BID ) and 200 mg once daily ( QD ) in patients with myelofibrosis
2024 · Yi Zhang, Hu Zhou, et al. · American Journal of Hematology · 8
PDF
Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
1993 · C W McCrady, F Li, et al. · PubMed · 8
Similar Survival But Less Chronic GVHD in Antithymocyte Globulin–Based Myeloablative Haploidentical Transplant Compared With Matched Sibling Transplant for Adult T-cell Acute Lymphoblastic Leukemia/Lymphoma
2024 · Zhenyang Gu, Fei Li, et al. · Cell Transplantation · 7
RETRACTED ARTICLE: MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4
2021 · Xianbao Huang, Ling Qi, et al. · Bioengineered · 5
Acute Myeloid Leukemia with Myelodysplasia-Related Changes in a Patient with Crohn’s Disease Treated with Immunosuppressive Therapy
2018 · Bowen Li, Zhenhua Zhu, et al. · Case Reports in Oncology · 4
Azacitidine, Homoharringtonine and Cytarabine Combined with Granulocyte Colony-Stimulating Factor As Frontline Treatment for Older Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase III Study in China
2024 · Yafang Ma, Xiang Zhang, et al. · Blood · 2
PDF
Preliminary safety and efficacy data of ICP-248, a novel BCL2 inhibitor, in patients with relapsed or refractory B-cell malignancies.
2025 · Shuhua YI, Keshu Zhou, et al. · Journal of Clinical Oncology · 1
Transcatheter Mitral Valve Replacement in Mixed Functional Mitral Regurgitation Addressing the Challenge of Minimal Neo-LVOT
2025 · Cunjun Zhu, Yuan He, et al. · JACC Case Reports · 1
A Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients with Relapsed/Refractory Acute Myeloid Leukemia
2023 · Junyuan Qi, Lin Song, et al. · Blood · 1
PDF
[Comparison of the Curative Efficacy of Elderly Patients with High-Risk MDS and MDS-Transformed AML between Decitabine Combined with Low-Dose CEG Regimen and Decitabine Combined with Low-Dose CAG Regimen].
2020 · Min Wu, Ie-Xian Ma, et al. · PubMed · 1
Zanubrutinib monotherapy in CD79B ‐mutated relapsed or refractory diffuse large B‐cell lymphoma: A multicenter Phase 2 study
2026 · Li Wang, Keshu Zhou, et al. · HemaSphere
PDF
Delayed Chimney Stent Fracture After Transcatheter Aortic Valve Replacement
2026 · Cunjun Zhu, Rongzhen Zhang, et al. · JACC Case Reports
Results of a registrational Phase 2 study of lisaftoclax monotherapy for treatment of patients (pts) with Relapsed/Refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who had failed Bruton's tyrosine kinase inhibitors (BTKis)
2025 · Keshu Zhou, Tingyu Wang, et al. · Blood
BGB-3111-218: Single-arm, open-label, multicenter study of the Bruton tyrosine kinase (BTK) inhibitor zanubrutinib (zanu) in patients with CD79B-mutated Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL)
2025 · Li Wang, Fei Li, et al. · Blood
PDF
TCT-374 Drug-coated balloon versus drug-eluting stent for treating coronary bifurcation lesions: insights from the REC-CAGEFREE I trial
2025 · Fei Li, Jianzheng Liu, et al. · Journal of the American College of Cardiology
S247: Adding Ruxolitinib and Decitabine to Bu/cy Conditioning Regimens to Prophylaxis Post-transplant Relapse in High-risk Aml Is Safe and Effective: a Prospective, Phase Ii Study
2023 · Yujun Wei, Kun Qian, et al. · HemaSphere
Data from miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma
2023 · Yijun Yang, Fei Li, et al.
Data from miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma
2023 · Yijun Yang, Fei Li, et al.
Increased risk of cardio-cerebrovascular disease after hematopoietic cell transplantation in patients with previous history
2021 · Bo Peng, Li-Li Wang, et al. · Chinese Medical Journal
Works count: 23
Citation count: 186
H-index: 7
I10-index: 4
Year
Topic
Type